HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application.

AbstractOBJECTIVES:
Complement activation product C5a plays a critical role in systemic inflammatory response syndrome induced by viruses, bacteria, and toxic agents including paraquat poisoning. This study is to explore the efficiency of anti-C5a-based intervention on systemic inflammatory responses induced by paraquat poisoning.
DESIGN:
Study of cynomolgus macaque model and plasma from paraquat-poisoning patients.
SETTING:
Laboratory investigation.
SUBJECTS:
Cynomolgus macaque (n = 12) and samples of plasma from patients (n = 16).
INTERVENTIONS:
The neutralizing antihuman C5a antibody (IFX-1) was administered to investigate the new treatment strategy for paraquat-induced systemic inflammatory responses in cynomolgus macaque model. In addition, C5a activation in plasma of paraquat patients was blocked by IFX-1 to investigate the blockade role of anti-C5a antibody in activation of inflammatory cells.
MEASUREMENTS AND MAIN RESULTS:
Dysregulated complement activation and the subsequent cytokine storm were found in patients with acute lung injury and in a primate model of paraquat poisoning. Targeted inhibition of C5a by IFX-1 led to marked alleviation of systemic inflammatory responses and multiple organ damage in the primate model. In addition, blockade of C5a activity in plasma from patients completely inhibited activation of CD11b on blood granulocytes from normal donors, suggesting that IFX-1 may alleviate the excessive activation of inflammatory responses and have clinical utility for patients with acute lung injury.
CONCLUSIONS:
Anti-C5a antibodies such as IFX-1 may be used as effective therapeutics for treatment of those suffering from systemic inflammatory responses induced by chemical poisoning like paraquat.
AuthorsShihui Sun, Yuting Jiang, Renxi Wang, Chenfeng Liu, Xiaoling Liu, Nianping Song, Yan Guo, Renfeng Guo, Lanying Du, Shibo Jiang, Yan Li, Zewu Qiu, Guangyu Zhao, Yusen Zhou
JournalCritical care medicine (Crit Care Med) Vol. 46 Issue 5 Pg. e419-e425 (05 2018) ISSN: 1530-0293 [Electronic] United States
PMID29293144 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neutralizing
  • Herbicides
  • Complement C5a
  • Paraquat
Topics
  • Acute Lung Injury (chemically induced, immunology, therapy)
  • Animals
  • Antibodies, Neutralizing (therapeutic use)
  • Complement Activation (immunology)
  • Complement C5a (antagonists & inhibitors, immunology)
  • Herbicides (toxicity)
  • Macaca fascicularis
  • Paraquat (toxicity)
  • Pulmonary Edema (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: